Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial)

BACKGROUND: We conducted a multicentre phase II trial to investigate feasibility and antitumor activity of sequential FOLFIRINOX and Stereotactic Body Radiotherapy (SBRT) in patients with locally advanced pancreatic cancer (LAPC), (LAPC-1 trial). METHODS: Patients with biopsy-proven LAPC treated in...

Description complète

Détails bibliographiques
Auteurs principaux: Suker, Mustafa, Nuyttens, Joost J., Eskens, Ferry A.L.M., Haberkorn, Brigitte C.M., Coene, Peter-Paul L.O., van der Harst, Erwin, Bonsing, Bert A., Vahrmeijer, Alexander L., Mieog, J.Sven D., Jan Swijnenburg, Rutger, Roos, Daphne, Koerkamp, B.Groot., van Eijck, Casper H.J.
Format: Online Article Texte
Langue:English
Publié: Elsevier 2019
Sujets:
Research Paper
Accès en ligne:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933188/
https://www.ncbi.nlm.nih.gov/pubmed/31891135
http://dx.doi.org/10.1016/j.eclinm.2019.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933188/
https://www.ncbi.nlm.nih.gov/pubmed/31891135
http://dx.doi.org/10.1016/j.eclinm.2019.10.013

Documents similaires